ACR 4.55% 6.3¢ acrux limited

Ann: Axiron Patents Appeal Decision, page-5

  1. 7,524 Posts.
    lightbulb Created with Sketch. 688
    "The launch of the generic versions of Axiron® made it no longer commercially viable to market Axiron® in the US, and the product was withdrawn from the US market on 5th September 2017"

    so I guess reducing the price and meeting the challenge of the generics headon was not an option??. more to this then meets the eye IMO - wonder if condition of Eli agreement dissolution was that ACR was unable to market its product in a generic form??

    transparency just like the Hexima matter hey!!!
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
-0.003(4.55%)
Mkt cap ! $18.31M
Open High Low Value Volume
6.5¢ 6.5¢ 6.2¢ $3.496K 54.39K

Buyers (Bids)

No. Vol. Price($)
2 75166 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 14538 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.